ImmunoGen Message Board - Msg: 14736178

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen

IMGN 31.23

0.0%

Feb 26 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Catherine who wrote (3667)	11/6/2000 11:55:18 AM
From: Gary Mohilner	Read Replies (2) of 5665

Catherine, The presentation's being made on the 10th, it's a Poster Presentation which I believe is scheduled to start at noon, but I'm not certain about that. I believe it was indicated it would be something like 2 or 4 a.m. eastern time. Conference abstracts are now posted on the AACR website, I believe the abstract is what was submitted some time ago, and I think the presentation will be brought up to date. The abstract can be found under Poster Session 20. To me the biggest thing in the abstract was the fact that the Pancreatic Patient has received 5 courses of treatment and the cancer's been stabile, no growth in 15 weeks with a very aggressive cancer. I'll try to post the link here later. Gary

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next